Zobrazeno 1 - 10
of 30
pro vyhledávání: '"P. Alagón-Fernández del Campo"'
Autor:
O. Morales Gutiérrez, A.K. Soto-Martínez, F.Y. Vargas-Durán, P. Alagón-Fernández del Campo, A.D. Santana-Vargas, J.E. Lira-Vera, M.F. Higuera-de la Tijera, J.L. Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100592- (2022)
Introduction and Objectives: Malnutrition is a frequent complication in patients with cirrhosis, associated with greater disease progression, complication rate, and mortality. Sarcopenia is one of the main indicators of malnutrition, characterized by
Externí odkaz:
https://doaj.org/article/18252d8785e044388476659338cdb5a3
Autor:
J.E. Lira-Vera, O. Morales-Gutiérrez, F.Y. Vargas-Durán, P. Alagón-Fernández del Campo, A.K. Soto-Martínez, G. Gutiérrez-Reyes, M. Martínez-Castillo, A.S. Sánchez-Valle, A. Hernández-Barragán, M. Hernández-Santillán, M.F. Higuera-de la Tijera, Y.L. Béjar-Ramírez, J.L. Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100606- (2022)
Introduction and Objectives: Metabolic syndrome and alcohol consumption are the two main causes of liver steatosis. Often, one of them predominates for its development and the other acts as a cofactor. The impact of these entities separately and thei
Externí odkaz:
https://doaj.org/article/0160555176724c74878d9fe7a71d2b6c
Autor:
Andrés Burak-Leipuner, Fatima Higuera-de la Tijera, Alfredo Servín-Caamaño, Javier Romero-Bermúdez, Laura Ceceña-Martínez, Felix García-Gorrosquieta, Kevin Vázquez-Hernández, Nidia Uribe-Rivera, Pablo Alagón-Fernández del Campo, Farid Vargas-Duran, Christian Hinojosa-Segura, Diana Montemira-Orozco, José Luis Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 101040- (2023)
Introduction and Objectives: Diabetes is a high-risk condition for the progression of metabolic fatty liver disease (MAFLD). The FAST® index combines the result of transition elastography (Fibroscan®) and AST levels and is used to predict the risk
Externí odkaz:
https://doaj.org/article/d1e73b40c161462e8138671d6f4b3106
Autor:
Jorge Emilio Lira-Vera, O Morales-Gutiérrez, Farid Yael Vargas-Durán, Pablo Alagón-Fernández Del Campo, Ana Karen Soto Martínez, Diana Montemira-Orozco, Andrés Burak-Leipuner, Christian Hinojosa-Segura, Gabriela Gutiérrez-Reyes, Moisés Martínez-Castillo, Samantha Sánchez-Valle, María De Los Ángeles Lemus-Peña, Daniel Montes De Oca-Ángeles, Abigail Hernández-Barragán, Marisela Hernández-Santillán, María De Fátima Higuera-De La Tijera, Yadira Lilian Béjar-Ramírez, José Luis Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100939- (2023)
Introduction and Objectives: metabolic syndrome and alcohol consumption are the leading causes of fatty liver disease. Now, a new term called dual damage has emerged. So far, no studies are reporting the prevalence of dual damage in Mexico. This stud
Externí odkaz:
https://doaj.org/article/febd60213e2b4ab9930d5d7ecbf650cb
Autor:
A Burak-Leipuner, F García-Gorrosquieta, N Uribe-Rivera, A Servín-Caamaño, JA Romero-Bermúdez, LE Ceceña-Martínez, P Alagón-Fernández del Campo, FY Vargas-Duran, AK Soto-Martinez, CI Hinojosa-Segura, D Montemira-Orozco, JL Perez-Hernández, G Alexanderson-Rosas, F Higuera-de la Tijera
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100789- (2022)
Introduction and Objective: Younossi ZM et al.have recently reported a higher prevalence of fatty liver disease associated with metabolic dysfunction (MAFLD) in diabetics (55.5%) versus the general population (25%); however, in Mexico, the prevalence
Externí odkaz:
https://doaj.org/article/af62f46b559145b2ab7b0adc425b2c7b
Autor:
JE Lira-Vera, O Morales-Gutiérrez, FY Vargas-Durán, P Alagón-Fernández del Campo, AK Soto Martínez, D Montemira-Orozco, A Burak-Leipuner, C Hinojosa-Segura, G Gutiérrez-Reyes, M Martínez-Castillo, S Sánchez-Valle, MA Lemus-Peña, D Montes de Oca-Ángeles, A Hernández-Barragán, M Hernández-Santillán, MF Higuera-de la Tijera, YL Béjar-Ramírez, JL Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100813- (2022)
Introduction and Objectives: To determine the prevalence of non-alcoholic fatty liver disease in a healthy population of the blood bank from Hospital General de México ''Dr. Eduardo Liceaga,'' as well as to describe the characteristics of the subjec
Externí odkaz:
https://doaj.org/article/9931c352a05840afb48bce503695e131
Autor:
JE Lira-Vera, O Morales-Gutiérrez, FY Vargas-Durán, P Alagón-Fernández del Campo, AK Soto Martínez, D Montemira-Orozco, A Burak-Leipuner, C Hinojosa-Segura, G Gutiérrez-Reyes, M Martínez-Castillo, S Sánchez-Valle, MA Lemus-Peña, D Montes de Oca-Ángeles, A Hernández-Barragán, M Hernández-Santillán, MF Higuera-de la Tijera, YL Béjar-Ramírez, JL Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100833- (2022)
Introduction and Objectives: This study aimed to determine the prevalence of non-alcoholic fatty liver disease due to alcohol consumption and combined damage in the healthy population of the blood bank of the Hospital General de México ''Dr. Eduardo
Externí odkaz:
https://doaj.org/article/97e3c2fef6464e55840158690563605a
Autor:
A Burak-Leipuner, F Higuera-de la Tijera, A Servín-Caamaño, J Romero-Bermúdez, L Ceceña-Martínez, F García-Gorrosquieta, N Uribe-Rivera, P Alagón-Fernández del Campo, F Vargas-Duran, C Hinojosa-Segura, D Montemira-Orozco, JL Pérez-Hernández
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100836- (2022)
Introduction and Objectives: Diabetes is a high-risk condition for the progression of metabolic fatty liver disease (MAFLD). The FAST index combines the result of transition elastography (Fibroscan®) and AST levels and is used to predict the risk of
Externí odkaz:
https://doaj.org/article/960749b09cd8475cbd05643fb2a118b2
Autor:
F. Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss, Pp 100610-(2022)
Introduction and Objectives: Clinical trials demonstrated the efficacy and safety of direct antiviral agents (DAA) to treat hepatitis C virus infection (HCV) in patients with decompensated cirrhosis (DC); however, very few real-world studies have bee
Autor:
F- Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Publikováno v:
Annals of Hepatology, Vol 27, Iss, Pp 100607-(2022)
Introduction and Objectives: If direct antiviral agents (DAA) are related to the development of HCC is controversial; therefore, exploring risk factors are crucial. We aimed to determine factors related to the development of hepatocellular carcinoma